Infliximab (Anti–Tumor Necrosis Factor Α Antibody)

Archives of Dermatology
doi 10.1001/archderm.137.12.1571
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Recognition of Human Tumor Necrosis Factor Α (TNF-α) by Therapeutic Antibody Fragment

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Vasculoprotective Effects of Anti-Tumor Necrosis Factor-Α Treatment in Aging

American Journal of Pathology
Forensic MedicinePathology
2007English

Reactivation of Hepatitis B Virus Following Anti-Tumor Necrosis Factor-Α Therapy

Soonchunhyang Medical Science
2013English

Interrelationships Between Infliximab and Recombinant Tumor Necrosis Factor- Α in Plasma Using Minimal Physiologically Based Pharmacokinetic Models

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2017English

Golimumab: A Novel Anti-Tumor Necrosis Factor

Biologics in Therapy
2013English

NF-κB; IL-1β; Tumor Necrosis Factor-Α (TNF-α)

Science-Business eXchange
2009English

Reactivation of Hepatitis B Virus Infection Associated With Anti-Tumor Necrosis Factor-Α Therapy

Journal of Antivirals & Antiretrovirals
2014English

Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: The CLASSIC-I Trial

Gastroenterology
HepatologyGastroenterology
2006English

Radiocurability by Targeting Tumor Necrosis Factor-Α Using a Bispecific Antibody in Carcinoembryonic Antigen Transgenic Mice

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy